Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-09 02:29 | 2023-02-06 | VERA | Vera Therapeutics, Inc. | Sofinnova Venture Partners X, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 285,714 | $1,999,998 | 3,467,156 | +9.0% |
| 2022-08-15 22:46 | 2022-08-11 | CINC | N/A | Sofinnova Venture Partners X, L.P. | 10% owner | Other | BUY | $30.00 | 500,000 | $15,000,000 | 6,073,949 | +9.0% |
| 2022-02-15 02:17 | 2022-02-10 | VERA | Vera Therapeutics, Inc. | Sofinnova Venture Partners X, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 266,666 | $3,999,990 | 3,181,442 | +9.1% |
| 2022-01-14 00:38 | 2022-01-11 | CINC | N/A | Sofinnova Venture Partners X, L.P. | 10% owner | Other | BUY | $16.00 | 325,000 | $5,200,000 | 5,573,949 | +6.2% |
| 2021-07-06 23:28 | 2021-07-02 | AVTE | Jade Biosciences, Inc. | Sofinnova Venture Partners X, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 357,142 | $4,999,988 | 3,758,686 | +10.5% |
| 2021-05-19 03:23 | 2021-05-18 | VERA | Vera Therapeutics, Inc. | Sofinnova Venture Partners X, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 727,272 | $7,999,992 | 2,914,776 | +33.2% |
| 2021-02-10 02:04 | 2021-02-09 | BOLT | Bolt Biotherapeutics, Inc. | Sofinnova Venture Partners X, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $20.00 | 450,000 | $9,000,000 | 2,754,437 | +19.5% |
| 2020-07-29 01:08 | 2020-07-28 | INZY | N/A | Sofinnova Venture Partners X, L.P. | 10% owner | Other | BUY | $16.00 | 437,500 | $7,000,000 | 2,028,308 | +27.5% |
| 2020-07-02 04:36 | 2020-06-30 | AKUS | N/A | Sofinnova Venture Partners X, L.P. | 10% owner | Other | BUY | $17.00 | 58,823 | $999,991 | 1,515,073 | +4.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.